BioLineRx Increases Stake in Biokine’s BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications – CBI
Homepage /  Press Release /  BioLineRx Increases Stake in Biokine’s BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications

Press Release

BioLineRx Increases Stake in Biokine’s BL-8040, its Lead Oncology Platform in Late Stage Development for Multiple Oncology Indications